Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Owens

Orthopaedic Surgery Clinton, SC Medical Doctor

NPI 1972552719 CMS profile 89692

22971 Highway 76 E, Clinton, SC 29325

Open in the dashboard

General payments

$3,591

24 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, William Owens of Clinton, SC is reported in the CMS Open Payments database as having received $3,591 across 24 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 50th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $305 7
2024 General $599 3
2023 General $2,168 7
2021 General $358 4
2020 General $12 1
2019 General $150 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Owens
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Owens were reported at $305. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Owens Orthopaedic Surgery median Middle half National median
2019 $150 $644 $140–$2,844 $163
2020 $12 $312 $75–$1,860 $114
2021 $358 $520 $117–$2,495 $132
2022 $0 $598 $128–$2,731 $149
2023 $2,168 $461 $128–$2,264 $160
2024 $599 $497 $134–$2,475 $164
2025 $305 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $2,099 5 payments
  2. DePuy Synthes Sales Inc. $584 2 payments
  3. Acumed LLC $466 5 payments
  4. Medical Device Business Services, Inc. $77 1 payment
  5. Wound Management Technologies, Inc $73 1 payment
  6. Peerless Surgical Inc. $73 2 payments
  7. Stryker Corporation $61 1 payment
  8. Masimo Corporation $39 1 payment
  9. Globus Medical, Inc. $27 1 payment
  10. Innocoll Incorporated $25 1 payment
  11. Other $68 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $2,219 4 payments
  2. Food and Beverage $1,372 20 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $2,099 5 payments
  2. AxoGuard Nerve Connector $2,068 4 payments
  3. AXOGUARD NERVE PROTECTOR $2,068 4 payments
  4. INHANCE $584 2 payments
  5. Acutrak Headless Compression Screw System $291 2 payments
  6. Anatomic Radial Head System $291 2 payments
  7. ACUMED Hand & Wrist $175 3 payments
  8. ACUMED Screw & Pin $175 3 payments
  9. ACUMED Shoulder $175 3 payments
  10. Hand Fracture System $149 1 payment
  11. Other $497 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

392

Median for Orthopedic Surgery: 203

Drug cost

$2,282

Median for Orthopedic Surgery: $1,433

Branded share of claims

73.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 287 $1,790
Hydromorphone Hcl Generic 42 $264
Clindamycin Hcl Generic 14 $109
Tramadol Hcl Generic 26 $72
Ondansetron Hcl Generic 11 $33
Amoxicillin Generic 12 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 136 billing codes

Paid by Medicare

$289,408

Of which drugs: $2,490

Medicare patients

602

Average age 74

Services billed

3,235

360 women, 242 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 70%
Diabetes 32%
Ischemic heart disease 29%
Depression 26%
Chronic kidney disease 24%
Atrial fibrillation 15%
Heart failure 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 97 352 $1,817

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

24 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record